帕金森病中神经血管改变与临床表型及白质损害的关系
The Relationship among the Neurovascular Changes, Clinical Phenotypes, and White Matter Impairment in Parkinson’s Disease
摘要: 帕金森病包含运动症状及非运动症状,临床表现存在显著异质性,黑质纹状体系统中多巴胺能神经元退行性改变不能完全解释临床表型异质性。近年来,随着神经影像学、生物标志物等检查及检验技术的发展,帕金森病中神经血管的结构及功能改变、早期且广泛的白质损害受到了越来越多的关注。本文通过总结既往帕金森病研究中已发现的特异性神经血管结构及功能改变、不同帕金森病临床表型间神经血管结构及功能的异同点、帕金森病中神经血管改变与白质损害及临床表型的关联性,发现了帕金森病中神经血管改变可能通过白质损害对临床表型产生影响,以期促进对帕金森病临床表型、病理生理机制、临床进展及预后的认识。
Abstract: Parkinson’s disease, manifesting both motor and non-motor symptoms, is characterized by its clinical heterogeneity, which can not be completely attributed to mechanisms of dopaminergic neuronal degeneration in striatal-nigral systems. Nowadays, with the development of neuroimaging and biomarkers, more researches focused on structural and functional neurovascular changes as well as early and extensive white matter impairments in Parkinson’s disease. Hence, we summarized specific structural and functional neurovascular changes in Parkinson’s disease, compared similarities and differences of neurovascular changes among different clinical phenotypes of Parkinson’s disease, and discussed the relationship between neurovascular changes and white matter alterations as well as clinical phenotypes of Parkinson’s disease based on recently reported researches. And we found that neurovascular changes may influence clinical phenotypes of Parkinson’s disease mainly via white matter impairments, aiming to broaden our views concerning clinical manifestations, pathophysiological mechanisms, clinical course and prognosis of Parkinson’s disease.
文章引用:李司晨, 诸玉霞, 赖泓宇, 达晓慧, 廖婷, 刘熙, 邓芬, 陈莉芬. 帕金森病中神经血管改变与临床表型及白质损害的关系[J]. 临床医学进展, 2024, 14(4): 1908-1916. https://doi.org/10.12677/acm.2024.1441243

参考文献

[1] Ng, A.S.L., Tan, Y.J., Yong, A.C.W., Saffari, S.E., Lu, Z., Ng, E.Y., Ng, S.Y.E., Chia, N.S.Y., Choi, X., Heng, D., Neo, S., Xu, Z., Keong, N.C.H., Tay, K.Y., Au, W.L., Tan, L.C.S. and Tan, E.K. (2020) Utility of Plasma Neurofilament Light as a Diagnostic and Prognostic Biomarker of the Postural Instability Gait Disorder Motor Subtype in Early Parkinson’s Disease. Molecular Neurodegeneration, 15, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[2] Chen, K., Jin, Z., Fang, J., Qi, L., Liu, C., Wang, R., Su, Y., Yan, H., Liu, A., Xi, J., Wen, Q. and Fang, B. (2023) The Impact of Cerebral Small Vessel Disease Burden and Its Imaging Markers on Gait, Postural Control, and Cognition in Parkinson’s Disease. Neurological Sciences, 44, 1223-1233. [Google Scholar] [CrossRef] [PubMed]
[3] Chen, H., Xu, E., Zhou, F., Li, Q., Zeng, J., Mei, S. and Xing, Y. (2022) Impaired Dynamic Cerebral Autoregulation: A Potential Mechanism of Orthostatic Hypotension and Dementia in Parkinson’s Disease. Frontiers in Aging Neuroscience, 14, Article 927009. [Google Scholar] [CrossRef] [PubMed]
[4] Yang, P., Pavlovic, D., Waldvogel, H., Dragunow, M., Synek, B., Turner, C., Faull, R. and Guan, J. (2015) String Vessel Formation Is Increased in the Brain of Parkinson Disease. Journal of Parkinsons Disease, 5, 821-836. [Google Scholar] [CrossRef
[5] Barnes, S.C., Panerai, R.B., Beishon, L., Hanby, M., Robinson, T.G. and Haunton, V.J. (2022) Cerebrovascular Responses to Somatomotor Stimulation in Parkinson’s Disease: A Multivariate Analysis. Journal of Cerebral Blood Flow and Metabolism, 42, 1547-1558. [Google Scholar] [CrossRef
[6] Gutteridge, D.S., Saredakis, D., Badcock, N.A., Collins-Praino, L.E. and Keage, H.A.D. (2020) Cerebrovascular Function during Cognition in Parkinson’s Disease: A Functional Transcranial Doppler Sonography Study. Journal of the Neurological Sciences, 408, Article ID: 116578. [Google Scholar] [CrossRef] [PubMed]
[7] Rektor, I., Goldemund, D., Sheardová, K., Rektorová, I., Michálková, Z. and Dufek, M. (2009) Vascular Pathology in Patients with Idiopathic Parkinson’s Disease. Parkinsonism & Related Disorders, 15, 24-29. [Google Scholar] [CrossRef] [PubMed]
[8] Jain, S., Ton, T.G., Perera, S., Zheng, Y., Stein, P.K., Thacker, E., Strotmeyer, E.S., Newman, A.B. and Longstreth Jr., W.T. (2012) Cardiovascular Physiology in Premotor Parkinson’s Disease: A Neuroepidemiologic Study. Movement Disorders, 27, 988-995. [Google Scholar] [CrossRef] [PubMed]
[9] Issidorides, M.R. (1971) Neuronal Vascular Relationships in the Zona Compacta of Normal and Parkinsonian Substantia Nigra. Brain Research, 25, 289-299. [Google Scholar] [CrossRef] [PubMed]
[10] Janelidze, S., Lindqvist, D., Francardo, V., Hall, S., Zetterberg, H., Blennow, K., Adler, C.H., Beach, T.G., Serrano, G.E., Van Westen, D., Londos, E., Cenci, M.A. and Hansson, O. (2015) Increased CSF Biomarkers of Angiogenesis in Parkinson Disease. Neurology, 85, 1834-1842. [Google Scholar] [CrossRef
[11] Tagliaferro, P. and Burke, R.E. (2016) Retrograde Axonal Degeneration in Parkinson Disease. Journal of Parkinsons Disease, 6, 1-15. [Google Scholar] [CrossRef
[12] Fearnley, J.M. and Lees, A.J. (1991) Ageing and Parkinson’s Disease: Substantia Nigra Regional Selectivity. Brain, 114, 2283-2301. [Google Scholar] [CrossRef] [PubMed]
[13] Pineda-Pardo, J.A., Sánchez-Ferro, Á., Monje, M.H.G., Pavese, N. and Obeso, J.A. (2022) Onset Pattern of Nigrostriatal Denervation in Early Parkinson’s Disease. Brain, 145, 1018-1028. [Google Scholar] [CrossRef] [PubMed]
[14] Tan, S.Y.Z., Keong, N.C.H., Selvan, R.M.P., Li, H., Ooi, L.Q.R., Tan, E.K. and Chan, L.L. (2019) Periventricular White Matter Abnormalities on Diffusion Tensor Imaging of Postural Instability Gait Disorder Parkinsonism. AJNR American Journal of Neuroradiology, 40, 609-613. [Google Scholar] [CrossRef
[15] Pelizzari, L., Laganà, M.M., Di Tella, S., Rossetto, F., Bergsland, N., Nemni, R., Clerici, M. and Baglio, F. (2019) Combined Assessment of Diffusion Parameters and Cerebral Blood Flow within Basal Ganglia in Early Parkinson’s Disease. Frontiers in Aging Neuroscience, 11, Article 134. [Google Scholar] [CrossRef] [PubMed]
[16] Gao, Y., Tang, H., Nie, K., Zhu, R., Gao, L., Feng, S., Wang, L., Zhao, J., Huang, Z., Zhang, Y. and Wang, L. (2019) Hippocampal Damage and White Matter Lesions Contribute to Cognitive Impairment in MPTP-Lesioned Mice with Chronic Cerebral Hypoperfusion. Behavioural Brain Research, 368, Article ID: 111885. [Google Scholar] [CrossRef] [PubMed]
[17] Nanhoe-Mahabier, W., De Laat, K.F., Visser, J.E., Zijlmans, J., De Leeuw, F.E. and Bloem, B.R. (2009) Parkinson Disease and Comorbid Cerebrovascular Disease. Nature Reviews Neurology, 5, 533-541. [Google Scholar] [CrossRef] [PubMed]
[18] Lee, J.M., Park, K.W., Seo, W.K., Park, M.H., Han, C., Jo, I. and Ahn Jo, S. (2007) Carotid Intima-Media Thickness in Parkinson’s Disease. Movement Disorders, 22, 2446-2449. [Google Scholar] [CrossRef] [PubMed]
[19] Zambito Marsala, S., Gioulis, M., Pistacchi, M. and Lo Cascio, C. (2016) Parkinson’s Disease and Cerebrovascular Disease: Is There a Link? A Neurosonological Case-Control Study. Neurological Sciences, 37, 1707-1711. [Google Scholar] [CrossRef] [PubMed]
[20] Zhang, C., Wu, B., Wang, X., Chen, C., Zhao, R., Lu, H., Zhu, H., Xue, B., Liang, H., Sethi, SK., Haacke, E.M., Zhu, J., Peng, Y. and Cheng, J. (2020) Vascular, Flow and Perfusion Abnormalities in Parkinson’s Disease. Parkinsonism & Related Disorders, 73, 8-13. [Google Scholar] [CrossRef] [PubMed]
[21] Liu, M., Xu, H., Wang, Y., Zhong, Y., Xia, S., Utriainen, D., Wang, T. and Haacke, E.M. (2015) Patterns of Chronic Venous Insufficiency in the Dural Sinuses and Extracranial Draining Veins and Their Relationship with White Matter Hyperintensities for Patients with Parkinson’s Disease. Journal of Vascular Surgery, 61, 1511-1520.E1. [Google Scholar] [CrossRef] [PubMed]
[22] Jagannath, V.A., Pucci, E., Asokan, G.V. and Robak, E.W. (2019) Percutaneous Transluminal Angioplasty for Treatment of Chronic Cerebrospinal Venous Insufficiency (CCSVI) in People with Multiple Sclerosis. The Cochrane Database of Systematic Reviews, 5, CD009903. [Google Scholar] [CrossRef
[23] Kim, J.S., Oh, Y.S., Lee, K.S., Song, I.U., Park, I.S., Yang, D.W., Koo, J.S. and Goldstein, D.S. (2014) Carotid Artery Thickening and Neurocirculatory Abnormalities in De Novo Parkinson Disease. Journal of Neural Transmission, 121, 1259-1268. [Google Scholar] [CrossRef] [PubMed]
[24] Nakaso, K., Yasui, K., Kowa, H., Kusumi, M., Ueda, K., Yoshimoto, Y., Takeshima, T., Sasaki, K. and Nakashima, K. (2003) Hypertrophy of IMC of Carotid Artery in Parkinson’s Disease Is Associated with L-DOPA, Homocysteine, and MTHFR Genotype. Journal of the Neurological Sciences, 207, 19-23. [Google Scholar] [CrossRef
[25] Rektor, I., Goldemund, D., Bednařík, P., Sheardová, K., Michálková, Z., Telecká, S., Dufek, M. and Rektorová, I. (2012) Impairment of Brain Vessels May Contribute to Mortality in Patients with Parkinson’s Disease. Movement Disorders, 27, 1169-1172. [Google Scholar] [CrossRef] [PubMed]
[26] Elabi, O., Gaceb, A., Carlsson, R., Padel, T., Soylu-Kucharz, R., Cortijo, I., Li, W., Li, J.Y. and Paul, G. (2021) Human α-Synuclein Overexpression in A Mouse Model of Parkinson’s Disease Leads to Vascular Pathology, Blood Brain Barrier Leakage and Pericyte Activation. Scientific Reports, 11, Article No. 1120. [Google Scholar] [CrossRef] [PubMed]
[27] Firbank, M.J., Colloby, S.J., Burn, D.J., McKeith, I.G. and O’Brien, J.T. (2003) Regional Cerebral Blood Flow in Parkinson’s Disease with and without Dementia. NeuroImage, 20, 1309-1319. [Google Scholar] [CrossRef
[28] Chun, M.Y., Chung, S.J., Kim, S.H., Park, C.W., Jeong, S.H., Lee, H.S., Lee, P.H., Sohn, Y.H., Jeong, Y. and Kim, Y.J. (2024) Hippocampal Perfusion Affects Motor and Cognitive Functions in Parkinson Disease: An Early Phase 18F-FP-CIT Positron Emission Tomography Study. Annals of Neurology, 95, 388-399. [Google Scholar] [CrossRef] [PubMed]
[29] Al-Bachari, S., Vidyasagar, R., Emsley, H.C. and Parkes, L.M. (2017) Structural and Physiological Neurovascular Changes in Idiopathic Parkinson’s Disease and Its Clinical Phenotypes. Journal of Cerebral Blood Flow and Metabolism, 37, 3409-3421. [Google Scholar] [CrossRef
[30] Shang, S., Wu, J., Chen, Y.C., Chen, H., Zhang, H., Dou, W., Wang, P., Cao, X. and Yin, X. (2021) Aberrant Cerebral Perfusion Pattern in Amnestic Mild Cognitive Impairment and Parkinson’s Disease with Mild Cognitive Impairment: A Comparative Arterial Spin Labeling Study. Quantitative Imaging in Medicine and Surgery, 11, 3082-3097. [Google Scholar] [CrossRef] [PubMed]
[31] Xiong, J., Zhu, H., Li, X., Hao, S., Zhang, Y., Wang, Z. and Xi, Q. (2023) Auto-Classification of Parkinson’s Disease with Different Motor Subtypes Using Arterial Spin Labelling MRI Based on Machine Learning. Brain Sciences, 13, Article 1524. [Google Scholar] [CrossRef] [PubMed]
[32] Shang, S., Ye, J., Wu, J., Zhang, H., Dou, W., Krishnan Muthaiah, V.P., Tian, Y., Zhang, Y., Chen, Y.C. and Yin, X. (2022) Early Disturbance of Dynamic Synchronization and Neurovascular Coupling in Cognitively Normal Parkinson’s Disease. Journal of Cerebral Blood Flow and Metabolism, 42, 1719-1731. [Google Scholar] [CrossRef
[33] Teune, L.K., Renken, R.J., De Jong, B.M., Willemsen, A.T., Van Osch, M.J., Roerdink, J.B., Dierckx, R.A. and Leenders, K.L. (2014) Parkinson’s Disease-Related Perfusion and Glucose Metabolic Brain Patterns Identified with PCASL-MRI and FDG-PET Imaging. NeuroImage Clinical, 5, 240-244. [Google Scholar] [CrossRef] [PubMed]
[34] Jeong, S.H., Kim, S.H., Park, C.W., Lee, H.S., Lee, P.H., Kim, Y.J., Sohn, Y.H., Jeong, Y. and Chung, S.J. (2023) Differential Implications of Cerebral Hypoperfusion and Hyperperfusion in Parkinson’s Disease. Movement Disorders, 38, 1881-1890. [Google Scholar] [CrossRef] [PubMed]
[35] Nakano, Y., Hirano, S., Kojima, K., Li, H., Sakurai, T., Suzuki, M., Tai, H., Furukawa, S., Sugiyama, A., Yamanaka,Y., Yamamoto, T., Iimori, T., Yokota, H., Mukai, H., Horikoshi, T., Uno, T. and Kuwabara, S. (2022) Dopaminergic Correlates of Regional Cerebral Blood Flow in Parkinsonian Disorders. Movement Disorders, 37, 1235-1244. [Google Scholar] [CrossRef] [PubMed]
[36] Chen, H., Xu, Y., Chen, L., Shang, S., Luo, X., Wang, X., Xia, W. and Zhang, H. (2022) The Convergent and Divergent Patterns in Brain Perfusion between Alzheimer’s Disease and Parkinson’s Disease with Dementia: An ASL MRI Study. Frontiers in Neuroscience, 16, Article 892374. [Google Scholar] [CrossRef] [PubMed]
[37] Yamashita, K., Hiwatashi, A., Togao, O., Kikuchi, K., Yamaguchi, H., Suzuki, Y., Kamei, R., Yamasaki, R., Kira, J.I. and Honda, H. (2017) Cerebral Blood Flow Laterality Derived from Arterial Spin Labeling as a Biomarker for Assessing the Disease Severity of Parkinson’s Disease. Journal of Magnetic Resonance Imaging, 45, 1821-1826. [Google Scholar] [CrossRef] [PubMed]
[38] Al-Bachari, S., Parkes, L.M., Vidyasagar, R., Hanby, M.F., Tharaken, V., Leroi, I. and Emsley, H.C. (2014) Arterial Spin Labelling Reveals Prolonged Arterial Arrival Time in Idiopathic Parkinson’s Disease. NeuroImage Clinical, 6, 1-8. [Google Scholar] [CrossRef] [PubMed]
[39] Ge, Y.L., Gong, S.Y., Wang, P.Z., Yan, J.H., Li, W., Zhang, J.R., Jin, H., Zhuang, S., Hu, L., Ding, C.W., Yang, Y.P., Wang, F., Li, D., Chen, J., Mao, C.J., Zhang, Y.C., Li, K. and Liu, C.F. (2022) Cognitive Performance Is Associated with Altered Cerebral Hemodynamics Assessed by Transcranial Ultrasound in Parkinson’s Disease. Neuropsychiatric Disease and Treatment, 18, 1421-1431. [Google Scholar] [CrossRef
[40] Pelizzari, L., Laganà, M.M., Rossetto, F., Bergsland, N., Galli, M., Baselli, G., Clerici, M., Nemni, R. and Baglio, F. (2019) Cerebral Blood Flow and Cerebrovascular Reactivity Correlate with Severity of Motor Symptoms in Parkinson’s Disease. Therapeutic Advances in Neurological Disorders, 12, 1-10. [Google Scholar] [CrossRef] [PubMed]
[41] Severiano, E.S.C., Alarcão, J., Pavão Martins, I. and Ferreira, J.J. (2022) Frequency of Dementia in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Journal of the Neurological Sciences, 432, Article ID: 120077. [Google Scholar] [CrossRef] [PubMed]
[42] Suo, X., Lei, D., Cheng, L., Li, N., Zuo, P., Wang, D.J.J., Huang, X., Lui, S., Kemp, G.J., Peng, R. and Gong, Q. (2019) Multidelay Multiparametric Arterial Spin Labeling Perfusion MRI and Mild Cognitive Impairment in Early Stage Parkinson’s Disease. Human Brain Mapping, 40, 1317-1327. [Google Scholar] [CrossRef] [PubMed]
[43] Syrimi, Z.J., Vojtisek, L., Eliasova, I., Viskova, J., Svatkova, A., Vanicek, J. and Rektorova, I. (2017) Arterial Spin Labelling Detects Posterior Cortical Hypoperfusion in Non-Demented Patients with Parkinson’s Disease. Journal of Neural Transmission, 124, 551-557. [Google Scholar] [CrossRef] [PubMed]
[44] Hattori, N., Yabe, I., Hirata, K., Shiga, T., Sakushima, K., Tsuji-Akimoto, S., Sasaki, H. and Tamaki, N. (2013) Brain Regions Associated with Cognitive Impairment in Patients with Parkinson Disease: Quantitative Analysis of Cerebral Blood Flow Using 123I Iodoamphetamine SPECT. Clinical Nuclear Medicine, 38, 315-320. [Google Scholar] [CrossRef
[45] Ma, X., Li, S., Li, C., Wang, R., Chen, M., Chen, H. and Su, W. (2021) Total Cerebral Small Vessel Score Association with Hoehn and Yahr Stage in Parkinson’s Disease. Frontiers in Aging Neuroscience, 13, Article 682776. [Google Scholar] [CrossRef] [PubMed]
[46] Della-Morte, D., Dong, C., Markert, M.S., Elkind, M.S.V., Sacco, R.L., Wright, C.B. and Rundek, T. (2018) Carotid Intima-Media Thickness Is Associated with White Matter Hyperintensities: The Northern Manhattan Study. Stroke, 49, 304-311. [Google Scholar] [CrossRef
[47] Ding, L., Hou, B., Zang, J., Su, T., Feng, F., Zhu, Z. and Peng, B. (2023) Imaging of Angiogenesis in White Matter Hyperintensities. Journal of the American Heart Association, 12, e028569. [Google Scholar] [CrossRef
[48] Oh, Y.S., Kim, J.S. and Lee, K.S. (2013) Orthostatic and Supine Blood Pressures Are Associated with White Matter Hyperintensities in Parkinson Disease. Journal of Movement Disorders, 6, 23-27. [Google Scholar] [CrossRef] [PubMed]
[49] Brisson, R.T., Fernandes, R.C.L., Arruda, J.F.L., Rocha, T., Santos, N.G.D., Silva, L.D., De Lima, M. and De Rosso, A.L.Z. (2023) Altered Cerebral Vasoreactivity on Transcranial Color-Coded Sonography Related to Akinetic-Rigid Phenotype of Parkinson’s Disease: Interim Analysis of a Cross-Sectional Study. Brain Sciences, 13, Article 709. [Google Scholar] [CrossRef] [PubMed]